The Evo team (Arc Institute)
November 14, 2024 02:00 PM ESTUpdated 03:04 PM
AI
Cell/Gene Tx

Arc In­sti­tute pub­lish­es new AI mod­el Evo, cre­at­ing CRISPR sys­tems in a leap for syn­thet­ic bi­ol­o­gy

Andrew Dunn

Senior Biopharma Correspondent

Less than a decade ago, a slew of star­tups like Metageno­mi and Mam­moth Bio­sciences raised huge sums of mon­ey …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: White House threat­ens ‘most fa­vored na­tion’ plan to low­er US drug prices, but many ques­tions re­main

Ex­clu­sive: Patrick Hsu start­up launch­es, looks be­yond CRISPR for gene in­ser­tion tech­nol­o­gy

Vir’s hep B dis­ap­point­ment, Ipsen's new Iqir­vo da­ta, plus more from #EASL25

Lack of de­tail in Trump's drug price plan rais­es more ques­tions than an­swers

Phar­ma in­vestors brush off Trump’s ‘most fa­vored na­tion’ plan as stocks rise

FDA clears in vi­vo blood stem cell edit­ing tri­al; Abeon­a's $155M PRV sale

A service from the Financial Times